retatrutide is it safe Retatrutide—A Game Changer in Obesity Pharmacotherapy The FDA has issued warning
Description
GLP-1 receptor agonists like semaglutide have helped millions lose weight by reducing appetite and improving blood sugar controlbut not everyone experiences the same results
Evidence of direct depletion: Weak Mechanistic plausibility via reduced intake: Moderate Symptoms of B12 Deficiency Neuropathy Fatigue Brain fog Macrocytic anaemia Persistent fatigue during GLP-1 therapy can have multiple causes, including caloric restriction and micronutrient shifts
This gives certainty regarding its clinical application (104)
Acta pharmacologica Sinica
